Medical Countermeasures Unlocking a New Target Against Crimean-Congo Hemorrhagic Fever VirusGlobal Biodefense StaffJuly 3, 2025
Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
Soligenix Wins Additional 4.3M to Advance Ricin Vaccine Manufacturing Contracts + Grants May 5, 2016 …
BARDA Awards Contract to Basilea for Broad-Spectrum Antibiotic Antimicrobial Resistance April 22, 2016 …
Federal Perspective on the State of Our Nation’s Biodefense Antimicrobial Resistance April 18, 2016 …
